In Matrigel transwell invasion assays, prostate cancer cells assayed in the presence of prototype mesotrypsin inhibitor showed a dose-dependent reduction in invasion relative to control cells (NT); 100 nM inhibitor was similar in effect to shRNA knockdown of PRSS3 (KD).
Next image